Sara Heydari - Publications
Affiliations: | National Institutes of Health-NINDS |
Year | Citation | Score | |||
---|---|---|---|---|---|
2013 | Nayak D, Johnson KR, Heydari S, Roth TL, Zinselmeyer BH, McGavern DB. Type I interferon programs innate myeloid dynamics and gene expression in the virally infected nervous system. Plos Pathogens. 9: e1003395. PMID 23737750 DOI: 10.1371/Journal.Ppat.1003395 | 0.626 | |||
2013 | Zinselmeyer BH, Heydari S, Sacristán C, Nayak D, Cammer M, Herz J, Cheng X, Davis SJ, Dustin ML, McGavern DB. PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis. The Journal of Experimental Medicine. 210: 757-74. PMID 23530125 DOI: 10.1084/Jem.20121416 | 0.602 | |||
2012 | Garidou L, Heydari S, Gossa S, McGavern DB. Therapeutic blockade of transforming growth factor beta fails to promote clearance of a persistent viral infection. Journal of Virology. 86: 7060-71. PMID 22553324 DOI: 10.1128/Jvi.00164-12 | 0.648 | |||
2009 | Truong P, Heydari S, Garidou L, McGavern DB. Persistent viral infection elevates central nervous system MHC class I through chronic production of interferons. Journal of Immunology (Baltimore, Md. : 1950). 183: 3895-905. PMID 19717517 DOI: 10.4049/Jimmunol.0803085 | 0.596 | |||
2009 | Garidou L, Heydari S, Truong P, Brooks DG, McGavern DB. Therapeutic memory T cells require costimulation for effective clearance of a persistent viral infection. Journal of Virology. 83: 8905-15. PMID 19553326 DOI: 10.1128/Jvi.00027-09 | 0.624 | |||
Show low-probability matches. |